Search

Your search keyword '"Nguyen, Ashley"' showing total 271 results

Search Constraints

Start Over You searched for: Author "Nguyen, Ashley" Remove constraint Author: "Nguyen, Ashley"
271 results on '"Nguyen, Ashley"'

Search Results

2. Building Capacity for Research on Community Doula Care: A Stakeholder-Engaged Process in California

4. “An extra layer of pressure to be my best self”: Healthcare provider perspectives on how doulas foster accountability and bridge gaps in pregnancy-related care

5. Supporting Birthing People and Supporting Doulas: The Impact of the COVID-19 Pandemic on a Community-Based Doula Organization in San Francisco.

13. Primary antibody deficiencies.

14. Practical and selective functionalizations of aromatics and heteroarenes via radical processes

15. Identification of potential antiviral compounds against SARS-CoV-2 structural and non structural protein targets: A pharmacoinformatics study of the CAS COVID-19 dataset

16. A brainstem peptide system activated at birth protects postnatal breathing

17. Septins provide microenvironment sensing and cortical actomyosin partitioning in motile amoeboid T lymphocytes

18. Talaporfin Sodium–Mediated Photodynamic Therapy Alone and in Combination with Pulsed Dye Laser on Cutaneous Vasculature

22. Depletion of tet2 results in age-dependent changes in DNA methylation and gene expression in a zebrafish model of myelodysplastic syndrome

23. Riluzole in Spinal Cord Injury Study (RISCIS)–Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial

26. Evaluation of the Impact of Meibomian Gland Dysfunction Using a Novel Patient-Reported Outcome Instrument.

29. Dynein-Powered Cell Locomotion Guides Metastasis of Breast Cancer

30. Supplemental Figure 7 from Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

31. Supplemental Figure Legends from Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

32. Supplemental Figure 1 from Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

33. Supplemental Figure 2C from Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

34. Supplemental Figure 6 from Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

35. Supplemental Figure 3A from Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

36. Supplemental Figure 5 from Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

37. Supplemental Figure 4C from Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

41. Garden From the Concrete Photo Book and Writer's memo

50. MM-349 Talquetamab (Tal), a GPRC5D×CD3 Bispecific Antibody (BsAb), in Combination With Pomalidomide (Pom) in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Efficacy and Safety Results From the Phase 1b MonumenTAL-2 Study

Catalog

Books, media, physical & digital resources